140 related articles for article (PubMed ID: 23196740)
1. Paediatric pharmacogenomics: an overview.
Hawcutt DB; Thompson B; Smyth RL; Pirmohamed M
Arch Dis Child; 2013 Mar; 98(3):232-7. PubMed ID: 23196740
[TBL] [Abstract][Full Text] [Related]
2. Pediatric perspective on pharmacogenomics.
Stevens A; De Leonibus C; Hanson D; Whatmore A; Murray P; Donn R; Meyer S; Chatelain P; Clayton P
Pharmacogenomics; 2013 Nov; 14(15):1889-905. PubMed ID: 24236488
[TBL] [Abstract][Full Text] [Related]
3. Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyond.
Leeder JS
Drug Discov Today; 2004 Jul; 9(13):567-73. PubMed ID: 15203092
[TBL] [Abstract][Full Text] [Related]
4. Implications of pharmacogenomics for drug development and clinical practice.
Ginsburg GS; Konstance RP; Allsbrook JS; Schulman KA
Arch Intern Med; 2005 Nov; 165(20):2331-6. PubMed ID: 16287761
[TBL] [Abstract][Full Text] [Related]
5. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
Shaller D
Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
[TBL] [Abstract][Full Text] [Related]
6. Alternative strategies in drug development: clinical pharmacological aspects.
Kuhlmann J
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
[TBL] [Abstract][Full Text] [Related]
7. NAVAGATE: a rubric to move from pharmacogenomics science to pharmacogenomics practice.
Roederer MW
Pharmacogenomics; 2012 Aug; 13(11):1307-13. PubMed ID: 22920399
[TBL] [Abstract][Full Text] [Related]
8. [Drug therapy at the beginning of the genomic era].
Stoica O; Braha E; Ungureanu G
Rev Med Chir Soc Med Nat Iasi; 2002; 107(2):240-6. PubMed ID: 12638267
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics: bench to bedside.
Weinshilboum R; Wang L
Nat Rev Drug Discov; 2004 Sep; 3(9):739-48. PubMed ID: 15340384
[TBL] [Abstract][Full Text] [Related]
10. [Translational approach for pharmacogenomics and personalized medicine].
Zhang W; Zhou HH
Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
[TBL] [Abstract][Full Text] [Related]
11. Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseases.
Piana C; Surh L; Furst-Recktenwald S; Iolascon A; Jacqz-Aigrain EM; Jonker I; Russo R; van Schaik RH; Wessels J; Della Pasqua OE
J Clin Pharmacol; 2012 May; 52(5):704-16. PubMed ID: 21566202
[TBL] [Abstract][Full Text] [Related]
12. Translating pharmacogenomics: challenges on the road to the clinic.
Swen JJ; Huizinga TW; Gelderblom H; de Vries EG; Assendelft WJ; Kirchheiner J; Guchelaar HJ
PLoS Med; 2007 Aug; 4(8):e209. PubMed ID: 17696640
[TBL] [Abstract][Full Text] [Related]
13. Developmental and pediatric pharmacogenomics.
Leeder JS
Pharmacogenomics; 2003 May; 4(3):331-41. PubMed ID: 12718723
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics: the implementation phase.
Sadee W
AAPS PharmSci; 2002; 4(2):E5. PubMed ID: 12141268
[TBL] [Abstract][Full Text] [Related]
15. Biomarker as a classifier in pharmacogenomics clinical trials: a tribute to 30th anniversary of PSI.
Wang SJ
Pharm Stat; 2007; 6(4):283-96. PubMed ID: 17957727
[TBL] [Abstract][Full Text] [Related]
16. Cambridge Healthtech Institute's 2nd Annual Conference on Pharmacogenomics Europe: presaging profits.
Kerb R; Brinkmann U
Pharmacogenomics; 2001 Aug; 2(3):303-5. PubMed ID: 11939136
[TBL] [Abstract][Full Text] [Related]
17. On pharmacogenomics in pharmacy benefit management.
Russell Teagarden J; Stanek EJ
Pharmacotherapy; 2012 Feb; 32(2):103-11. PubMed ID: 22392418
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
Yan L; Beckman R
Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics in the assessment of therapeutic risks versus benefits: inside the United States Food and Drug Administration.
Zineh I; Pacanowski MA
Pharmacotherapy; 2011 Aug; 31(8):729-35. PubMed ID: 21923598
[TBL] [Abstract][Full Text] [Related]
20. Relevance of pharmacogenomics for developing countries in Europe.
Mitropoulos K; Johnson L; Vozikis A; Patrinos GP
Drug Metabol Drug Interact; 2011; 26(4):143-6. PubMed ID: 22017487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]